-
RKDA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Arcadia Biosciences (RKDA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.94 mm | 3.94 mm | 3.94 mm | 3.94 mm | 3.94 mm | 3.94 mm |
Cash burn (monthly) | 522.67 k | 556.25 k | 586.67 k | 989.42 k | 584.00 k | 964.08 k |
Cash used (since last report) | 2.67 mm | 2.84 mm | 2.99 mm | 5.05 mm | 2.98 mm | 4.92 mm |
Cash remaining | 1.27 mm | 1.10 mm | 944.06 k | -1.11 mm | 957.66 k | -980.72 k |
Runway (months of cash) | 2.4 | 2.0 | 1.6 | -1.1 | 1.6 | -1.0 |
13F holders | Current |
---|---|
Total holders | 9 |
Opened positions | 2 |
Closed positions | 6 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 108.90 mm |
Total shares | 2.22 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Moral Compass | 1.13 mm | $0.00 |
Intracoastal Capital | 1.06 mm | $1.10 mm |
Mariner | 25.00 k | $68.25 mm |
Vanguard | 14.04 k | $39.31 mm |
Advisor | 75.00 | $205.00 k |
USB U.S. Bancorp | 5.00 | $14.00 k |
Assetmark | 5.00 | $14.00 k |
Oliver Lagore Vanvalin Investment | 4.00 | $11.00 k |
Harbour Investments | 1.00 | $3.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Feb 25 | Thomas J. Schaefer | Common Stock | Buy | Acquire P | No | No | 2.49 | 700 | 1.74 k | 2,819 |
3 Feb 25 | Mark Kawakami | Common Stock | Buy | Acquire P | No | No | 2.49 | 700 | 1.74 k | 2,681 |
19 Aug 24 | Mark Kawakami | Stock Option Common Stock | Grant | Acquire A | No | No | 2.71 | 20,000 | 54.20 k | 21,487 |
19 Aug 24 | Thomas J. Schaefer | Stock Option Common Stock | Grant | Acquire A | No | No | 2.71 | 20,000 | 54.20 k | 25,475 |
19 Aug 24 | Yoder Amy | Stock Option Common Stock | Grant | Acquire A | No | No | 2.71 | 10,909 | 29.56 k | 13,442 |